Browse > Article
http://dx.doi.org/10.1016/j.jgr.2015.09.004

Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells  

Hwang, Ji Yeon (Department of Physiology, School of Medicine, Kyung Hee University)
Shim, Ji Seon (Department of Physiology, School of Medicine, Kyung Hee University)
Song, Min-Young (Department of Physiology, School of Medicine, Kyung Hee University)
Yim, Sung-Vin (Department of Clinical Pharmacology, School of Medicine, Kyung Hee University)
Lee, Seung Eun (Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science)
Park, Kang-Sik (Department of Physiology, School of Medicine, Kyung Hee University)
Publication Information
Journal of Ginseng Research / v.40, no.3, 2016 , pp. 278-284 More about this Journal
Abstract
Background: The ginsenoside Rb1 (Rb1) is the most abundant compound in the root of Panax ginseng. Recent studies have shown that Rb1 has a neuroprotective effect. However, the mechanisms underlying this effect are still unknown. Methods: We used stable isotope labeling with amino acids in cell culture, combined with quantitative mass spectrometry, to explore a potential protective mechanism of Rb1 in ${\beta}$-amyloid-treated neuronal cells. Results: A total of 1,231 proteins were commonly identified from three replicate experiments. Among these, 40 proteins were significantly changed in response to Rb1 pretreatment in ${\beta}$-amyloid-treated neuronal cells. Analysis of the functional enrichments and protein interactions of altered proteins revealed that actin cytoskeleton proteins might be linked to the regulatory mechanisms of Rb1. The CAP1, CAPZB, TOMM40, and DSTN proteins showed potential as molecular target proteins for the functional contribution of Rb1 in Alzheimer's disease (AD). Conclusion: Our proteomic data may provide new insights into the protective mechanisms of Rb1 in AD.
Keywords
actin skeleton; Alzheimer's disease; ${\beta}$-amyloid; ginsenoside Rb1; mass spectrometry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cho WC, Yip TT, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KKM. Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS. J Ethnopharmacol 2006;108:272-9.   DOI
2 Ma ZC, Gao Y, Wang YG, Tan HL, Xiao CR, Wang SQ. Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha. Acta Pharmacol Sin 2006;27:1000-6.   DOI
3 Choi JW, Song MY, Park KS. Quantitative proteomic analysis reveals mitochondrial protein changes in MPP(+)-induced neuronal cells. Mol Biosyst 2014;10:1940-7.   DOI
4 Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011;39:D561-8.   DOI
5 Abeti R, Abramov AY, Duchen MR. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 2011;134:1658-72.   DOI
6 Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler RW, Lane HC, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007;35:W169-75.   DOI
7 McMurray CT. Neurodegeneration: diseases of the cytoskeleton? Cell Death Differ 2000;7:861-5.   DOI
8 Li H, Zhu YH, Chi C, Wu HW, Guo J. Role of cytoskeleton in axonal regeneration after neurodegenerative diseases and CNS injury. Rev Neurosci 2014;25:527-42.
9 Penzes P, Vanleeuwen JE. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease. Brain Res Rev 2011;67:184-92.   DOI
10 Kao PF, Davis DA, Banigan MG, Vanderburg CR, Seshadri S, Delalle I. Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease. PLoS One 2010;5:e13337.   DOI
11 Zhang H, Ghai P, Wu H, Wang C, Field J, Zhou GL. Mammalian adenylyl cyclase-associated protein 1 (CAP1) regulates cofilin function, the actin cytoskeleton, and cell adhesion. J Biol Chem 2013;288:20966-77.   DOI
12 Yamazaki K, Takamura M, Masugi Y, Mori T, Du W, Hibi T, Hiraoka N, Ohta T, Ohki M, Hirohashi S. Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest 2009;89:425-32.   DOI
13 He J, Whelan SA, Lu M, Shen D, Chung DU, Saxton RE, Faull KF, Whitelegge JP, Chang HR. Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response. Int J Proteomics 2011;2011:896476.
14 Moriyama K, Yahara I. Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover. J Cell Sci 2002;115:1591-601.
15 Zhu X, Yao L, Guo A, Li A, Sun H, Wang N, Liu H, Duan Z, Cao J. CAP1 was associated with actin and involved in Schwann cell differentiation and motility after sciatic nerve injury. J Mol Histol 2014;45:337-48.   DOI
16 Mitake S, Ojika K, Hirano A. Hirano bodies and Alzheimer's disease. Kaohsiung J Med Sci 1997;13:10-8.
17 Delalle I, Pfleger CM, Buff E, Lueras P, Hariharan IK. Mutations in the Drosophila orthologs of the F-actin capping protein alpha- and beta-subunits cause actin accumulation and subsequent retinal degeneration. Genetics 2005;171:1757-65.   DOI
18 Klose T, Abiatari I, Samkharadze T, De Oliveira T, Jager C, Kiladze M, Valkovska N, Friess H, Michalski CW, Kleeff J. The actin binding protein destrin is associated with growth and perineural invasion of pancreatic cancer. Pancreatology 2012;12:350-7.   DOI
19 Davis DA, Wilson MH, Giraud J, Xie Z, Tseng HC, England C, Herscovitz H, Tsai LH, Delalle I. Capzb2 interacts with beta-tubulin to regulate growth cone morphology and neurite outgrowth. PLoS Biol 2009;7:e1000208.   DOI
20 Tian L, Liao MF, Zhang L, Lu QS, Jing ZP. A study of the expression and interaction of Destrin, cofilin, and LIMK in Debakey I type thoracic aortic dissection tissue. Scand J Clin Lab Invest 2010;70:523-8.   DOI
21 Barone E, Mosser S, Fraering PC. Inactivation of brain Cofilin-1 by age, Alzheimer's disease and gamma-secretase. Biochim Biophys Acta 2014;1842:2500-9.   DOI
22 Elias-Sonnenschein LS, Helisalmi S, Natunen T, Hall A, Paajanen T, Herukka SK, Laitinen M, Remes AM, Koivisto AM, Mattila KM, et al. Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish casecontrol cohort. PLoS One 2013;8:e59676.   DOI
23 Chong MS, Goh LK, Lim WS, Chan M, Tay L, Chen G, Feng L, Ng TP, Tan CH, Lee TS. Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer's disease. J Alzheimers Dis 2013;34:399-405.   DOI
24 Chen X, Huang T, Zhang J, Song J, Chen L, Zhu Y. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons. Brain Res 2008;1200:99-106.   DOI
25 Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992;36:27-38.   DOI
26 Radad K, Gille G, Liu L, Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 2006;100:175-86.   DOI
27 Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:222-6.   DOI
28 Van Kampen JM, Baranowski DB, Shaw CA, Kay DG. Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease. Exp Gerontol 2014;50:95-105.   DOI
29 Liao B, Newmark H, Zhou R. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp Neurol 2002;173:224-34.   DOI
30 Yoshikawa T, Akiyoshi Y, Susumu T, Tokado H, Fukuzaki K, Nagata R, Samukawa K, Iwao H, Kito G. Ginsenoside Rb1 reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates. J Pharmacol Sci 2008;107:32-40.   DOI
31 Lim JH, Wen TC, Matsuda S, Tanaka J, Maeda N, Peng H, Aburaya J, Ishihara K, Sakanaka M. Protection of ischemic hippocampal neurons by ginsenoside $Rb_{1}$, a main ingredient of ginseng root. Neurosci Res 1997;28:191-200.   DOI
32 Wang Y, Liu J, Zhang Z, Bi P, Qi Z, Zhang C. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease. Neurosci Lett 2011;487:70-2.   DOI
33 Wang Y, Feng Y, Fu Q, Li L. Panax notoginsenoside Rb1 ameliorates Alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expression. Exp Ther Med 2013;6:826-30.   DOI
34 Xie X, Wang HT, Li CL, Gao XH, Ding JL, Zhao HH, Lu YL. Ginsenoside Rb1 protects PC12 cells against beta-amyloid-induced cell injury. Mol Med Rep 2010;3:635-9.
35 Qian YH, Han H, Hu XD, Shi LL. Protective effect of ginsenoside Rb1 on beta-amyloid protein(1-42)-induced neurotoxicity in cortical neurons. Neurol Res 2009;31:663-7.   DOI
36 Han G, Sun J, Wang J, Bai Z, Song F, Lei H. Genomics in neurological disorders. Genomics Proteomics Bioinformatics 2014;12:156-63.   DOI
37 Sowell RA, Owen JB, Butterfield DA. Proteomics in animal models of Alzheimer's and Parkinson's diseases. Ageing Res Rev 2009;8:1-17.   DOI
38 Sultana R, Butterfield DA. Redox proteomics studies of in vivo amyloid betapeptide animal models of Alzheimer's disease: insight into the role of oxidative stress. Proteomics Clin Appl 2008;2:685-96.   DOI
39 Swomley AM, Forster S, Keeney JT, Triplett J, Zhang Z, Sultana R, Butterfield DA. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim Biophys Acta 2014;1842:1248-57.   DOI
40 Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW, Park JH. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 2009;73:811-6.   DOI